ArticleRSC medicinal chemistry2024

Design, synthesis and preliminary biological evaluation of rivastigmine-INDY hybrids as multitarget ligands against Alzheimer's disease by targeting butyrylcholinesterase and DYRK1A/CLK1 kinases.

Mihaela-Liliana Ţînţaş et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.